Background Current treatment guidelines for limited‐stage small‐cell lung cancer (SCLC)
recommend concomitant platinum‐based chemo‐radiotherapy plus prophylactic cranial …

Microfluidic devices as translational research tools provide a potential alternative to animal
experiments due to their ability to mimic physiological parameters. Several approaches that …

Background Exercise capacity should be determined in all patients undergoing lung
resection for lung cancer surgery and cardiopulmonary exercise testing (CPET) remains the …

Purpose Data on optimal adjuvant therapy after complete resection of small-cell lung cancer
(SCLC) are limited, and in particular, there have been no studies evaluating the role of …

Background: Very few population based results have been presented for survival after
resection for lung cancer. The purpose of this study was to present long term survival after …

Small cell lung cancer (SCLC) is a highly aggressive lung neoplasm with extremely poor
clinical outcomes and no approved targeted treatments. To elucidate the mechanisms …

Objective Since data from large retrospective observational studies and cancer registries
became available, suggesting a benefit for patients undergoing surgery, the role of surgery …

Simple Summary Small-cell lung cancer (SCLC) accounts for approximately 15% of all lung
cancers and is one of the most aggressive tumors, with poor prognosis and limited …

Purpose This systematic review addressed the following key questions on managing small
cell lung cancer (SCLC): the sequence, timing, and dosing characteristics of primary thoracic …

Background Primary small cell carcinoma of the esophagus (SCCE) is characterized as
highly aggressive with a poor prognosis. To identify potential prognostic factors and to …